Wednesday, February 8, 2023 | Back issues
Courthouse News Service Courthouse News Service

Liver disease drug

NEW YORK — A Manhattan appeals court dismissed a securities fraud class action against French pharmaceutical firm Genfit over its drug to treat liver disease, finding the company disclosed clinical trial results and said its profitability could not be guaranteed.

Click here to read the ruling.    

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.